FDA 483 - EMSL Analytical, Inc. dba MPL Laboratories - May 21, 2026

EMSL Analytical, Inc. DBA MPL Laboratories in Sparta, NJ, a control testing laboratory, was cited for significant deficiencies during an FDA inspection. Observations included a lack of established and documented test method suitability and transfer, inadequate equipment calibration and software validation, and insufficient controls over computerized records. These issues indicate a failure to ensure the integrity and reliability of laboratory testing and data.